Tariq I Mughal

Tariq I Mughal

UNVERIFIED PROFILE

Are you Tariq I Mughal?   Register this Author

Register author
Tariq I Mughal

Tariq I Mughal

Publications by authors named "Tariq I Mughal"

Are you Tariq I Mughal?   Register this Author

32Publications

956Reads

48Profile Views

Comprehensive Genomic Profiling Reveals Diverse but Actionable Molecular Portfolios across Hematologic Malignancies: Implications for Next Generation Clinical Trials.

Cancers (Basel) 2018 Dec 21;11(1). Epub 2018 Dec 21.

Department of Medicine, Division of Hematology/Oncology and Center for Personalized Cancer Therapy, University of California San Diego, 3855 Health Science Drive #0987, La Jolla, CA 92093, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers11010011DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6356731PMC
December 2018

Chronic Myeloproliferative Neoplasms: Some Remaining Challenges.

Hemasphere 2018 Oct 2;2(5):e147. Epub 2018 Oct 2.

University of California Irvine, Irvine, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/HS9.0000000000000147DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6407801PMC
October 2018

Topical, Biological and Clinical Challenges in the Management of Patients with Acne Vulgaris.

Sultan Qaboos Univ Med J 2016 May 15;16(2):e152-60. Epub 2016 May 15.

Department of Hematology & Oncology, Tufts University Medical Center, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
https://journals.squ.edu.om/index.php/squmj/article/viewFile
Publisher Site
http://dx.doi.org/10.18295/squmj.2016.16.02.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4868513PMC
May 2016

Myelofibrosis-associated complications: pathogenesis, clinical manifestations, and effects on outcomes.

Int J Gen Med 2014 29;7:89-101. Epub 2014 Jan 29.

Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/IJGM.S51800DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3912063PMC
February 2014

Principal long-term adverse effects of imatinib in patients with chronic myeloid leukemia in chronic phase.

Biologics 2010 Dec 2;4:315-23. Epub 2010 Dec 2.

University of Tennessee Medical College, Memphis, Tennessee, USA;

View Article

Download full-text PDF

Source
http://www.dovepress.com/principal-long-term-adverse-effects
Publisher Site
http://dx.doi.org/10.2147/BTT.S5775DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3010822PMC
December 2010

An integrated clinical approach for the identification, prevention, and treatment of tumor lysis syndrome.

Cancer Treat Rev 2010 Apr 23;36(2):164-76. Epub 2009 Dec 23.

Department of Haematology, Guy's & St Thomas's NHS Hospital, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2009.11.001DOI Listing
April 2010

Port-wine-flavour bone-marrow sandwiches and beyond.

Lancet Oncol 2009 Sep;10(9):926

Department of Haematology, Guy's and St Thomas NHS Foundation Hospital, London SE1 9RT, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(09)70146-9DOI Listing
September 2009

Emerging strategies for the treatment of mutant Bcr-Abl T315I myeloid leukemia.

Clin Lymphoma Myeloma 2007 Mar;7 Suppl 2:S81-4

Division of Hematology and Stem Cell Transplantation, University of Texas Southwestern Medical School, Dallas 75390, USA.

View Article

Download full-text PDF

Source
March 2007

Novel approaches in the management of myeloma-related skeletal complications.

Support Cancer Ther 2006 Oct;4(1):15-8

CIG Media Group, LP, Dallas, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/SCT.2006.n.026DOI Listing
October 2006

Current data with mammalian target of rapamycin inhibitors in advanced-stage renal cell carcinoma.

Clin Genitourin Cancer 2006 Sep;5(2):110-3

CIG Media Group, LP, Dallas, TX, USA.

View Article

Download full-text PDF

Source
September 2006

Chronic myeloid leukemia: why does it evolve from chronic phase to blast transformation?

Front Biosci 2006 Jan 1;11:198-208. Epub 2006 Jan 1.

Division of Hematology and Oncology, University of Massachusetts Medical School, Worcester, MA 01655, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2741/1791DOI Listing
January 2006

Molecularly targeted treatment of chronic myeloid leukemia: beyond the imatinib era.

Front Biosci 2006 Jan 1;11:209-20. Epub 2006 Jan 1.

Division of Hematology and Oncology, University of Massachusetts Medical School, Worcester, Massachusetts 01655, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2741/1792DOI Listing
January 2006

Current and future use of hematopoietic growth factors in cancer medicine.

Authors:
Tariq I Mughal

Hematol Oncol 2004 Sep;22(3):121-34

CRC Division of Medical Oncology, Christie Hospital & Institute of Cancer Research, University of Manchester School of Medicine, Manchester, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hon.736DOI Listing
September 2004

Chronic myeloid leukemia: current status and controversies.

Oncology (Williston Park) 2004 Jun;18(7):837-44, 847; discussion 847-50, 853-4

Department of Haematology, Hammersmith Hospital at the Imperial College London, London, United Kingdom.

View Article

Download full-text PDF

Source
June 2004